The Wall Street Journal
Investor Testifies as Case Against Elizabeth Holmes Winds Down
SAN JOSE, Calif.—A Texas money manager who invested more than $1 million in Theranos Inc. when it was still an early-stage healthcare startup took the stand Wednesday in the criminal-fraud trial of founder to detail the promises she made that helped convince him to back the company. The testimony of Alan Eisenman underpins one of the wire fraud charges Ms. Holmes faces in a 12-count indictment, and builds on similar stories jurors have heard from other investors at trial. Mr. Eisenman recounted how Theranos was the first biotechnology company he had ever invested in, and that he learned about the company through a close friend in Houston who was a financial adviser to Ms. Holmes’s family.
